Unknown

Dataset Information

A pro-atherogenic HDL profile in coronary heart disease patients: an iTRAQ labelling-based proteomic approach.


ABSTRACT:

Objectives

This study aims to compare the protein composition of high-density lipoprotein (HDL) particles in coronary heart disease (CHD) patients and controls by proteomic methods.

Background

HDL has been reported to exert pro-atherogenic properties in CHD patients. Accumulating evidence indicates that HDL composition, rather than the HDL-C level, determines its functions. The changes in HDL composition involved in the conversion of anti-atherogenic to pro-atherogenic properties in CHD patients are currently unknown.

Methods and results

iTRAQ combined with nanoLC-MS/MS was performed to obtain a differential expression profile of the HDL pooled samples of the male age-matched CHD patients and controls (n = 10/group). Of the 196 proteins identified in the examined HDL,

SUBMITTER: Yan LR 

PROVIDER: S-EPMC4032332 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature